Neudle.com: dilantin toxicity

Differential
(Click to cross reference)

abducens nerve paralysis

abortion, spontaneous

acetazolamide

acquired immunodeficiency syndrome dementia complex

acute cerebellar ataxia

acute intermittant porphyria

advances in neurology

adverse drug reaction

anemia, megaloblastic

antibiotics, neurologic complications with

anticholinergic drugs

anticholinergic drugs, side effects of

anticholinesterase

anticoagulant, complications of

anticonvulsants

anticonvulsants, absorption

anticonvulsants, bioavailability

anticonvulsants, blood level determination of

anticonvulsants, brand name

anticonvulsants, cognitive function with

anticonvulsants, compliance

anticonvulsants, discontinuation in seizure-free epileptics

anticonvulsants, dosage

anticonvulsants, effectiveness

anticonvulsants, enzyme inducing

anticonvulsants, generic

anticonvulsants, hypersensitivity syndrome

anticonvulsants, loading dose

anticonvulsants, mechanism of action of

anticonvulsants, metabolism

anticonvulsants, parenteral administration

anticonvulsants, pharmacokinetics

anticonvulsants, selection of

anticonvulsants, teratogenicity of

anticonvulsants, untoward effects of

atrioventricular block

Bassen-Kornzweig syndrome

bee sting

bee sting, neurologic complications with

behavioral disorder

benign essential tremor

benzodiazepine

beta adrenergic blocker

blood dyscrasias, neurologic findings with

bone density

bone loss

bone marrow transplantation

burst suppression pattern, electroencephalogram

busulfan

caffeine

calcium antagonist

calcium antagonist, side effects of

carbamazepine, toxicity

central nervous system, infection of

cerebellar ataxia, children

cerebellar ataxia, children, differential diagnosis of

cerebellar atrophy, secondary

cerebellar degeneration

cerebrospinal fluid, elevated protein of

chemotherapy, CNS treatment and complications with

color vision, impaired

congenital birth defects

congenital deformities

congenital heart disease

congenital heart disease, CNS complications with

congenital malformation

congenital malformation, dilantin therapy causing

congenital malformation, non CNS

contrast agents, neurotoxicity of

corpus callosum

corpus callosum, lesion of

creatine phosphokinase(CPK)elevated

developmental evaluation

developmental retardation

diabetes insipidus

digits, abnormal

dilantin

dilantin, factors influencing metabolism of

dilantin, hypersensitivity to

dilantin, intravenous

dilantin, saliva level

dilantin, serum level

dilantin, toxicity

diltiazem

diplopia

disseminated intravascular coagulation(DIC)

drug induced neurologic disorders

drug induced neurologic disorders in children

dyskinesia, buccal lingual facial

electrocardiogram, abnormal

electroencephalogram

electroencephalogram, abnormalities of

electromyogram

embryogenesis

emergencies, neurologic

encephalitis

encephalitis, human immunodeficiency virus type 1

epidemiology of neurology

epilepsy

epilepsy referral centers

eye movement, disorders of

fetal valproate syndrome

fetus

fever

fingernails, abnormal

fingernails, hypoplastic

folic acid antagonists

folic acid deficiency

fosphenytoin

gabapentin

gamma amino butyric acid

gender

generic drugs

genetic counselling

genetic neurologic disorders

hallucination, visual

heavy metal intoxication

hemihyperesthesia

hemiparesis

hemisensory loss

hemorrhagic diathesis

hepatic failure

hepatitis

heralding manifestation

human immunodeficiency virus type 1

hyperactivity

hyperammonemic encephalopathy

hypersensitivity reaction

hypogammaglobulinemia

hypoglycemia

hypospadias

hypotension, systemic

hypoxia

iatrogenic neurologic disorders

intelligence quotient

intelligence testing in children

level of consciousness, decreased

liver function enzymes

lorazepam

lordosis

lymphadenopathy

malformation, CNS, congenital

malignant hyperpyrexia

manic-depressive

marihuana

memory, impairment of

meningitis

menses, seizure with

mental retardation

mental status, abnormal

mexiletine

microcephaly

midline defect in children

movement disorder, drug induced

movement disorder, extrapyramidal

movement disorder, treatment of

MRI

MRI, abnormal

MRI, disappearing lesion on

muscle weakness, proximal

myasthenia gravis

myasthenia gravis, drug induced

myasthenia gravis, unmasked

myopathy, drug-induced

myotonia, treatment of

neuromuscular blockade

neuromuscular junction, abnormality of

neuropathy

neuropathy, iatrogenic

neuropathy, medication induced

neuropathy, peripheral

nystagmus, periodic alternating

nystagmus, primary position of gaze

obstetric neurologic injuries

ocular motility, disorders of

oculocephalic reflex

oculovestibular reflex

old age, neurology of

ophthalmoplegia

ophthalmoplegia, total

optic neuritis

optokinetic nystagmus(O.K.N.)

oral contraceptives

oral contraceptives, neurologic complications with

pain, management of chronic

paraldehyde

paramethadione

paroxetine

patient information and support

penicillamine

penicillin

percussion induced muscle contraction

periarteritis nodosa

personality disorder

phantom limb

phencyclidine poisoning

poison, neurologic problems with

polydactyly

polymyositis

polypharmacy

postoperative neurologic complications

practice guidelines

pregabalin

pregnancy, anticonvulsants during

pregnancy, neurologic complications in

prenatal

prenatal diagnosis by amniocentesis

prevention of neurologic disorders

psychiatric problems in neurologic disorders

psychological testing

psychological testing, children

psychomotor retardation

psychosis

ptosis

pulmonary edema

pulmonary function tests

pulmonary infiltrates

pupil, dilated, bilateral

Purkinje cell

purple glove syndrome

respiratory depression

respiratory failure

respiratory paralysis, pharmacologic

review article

rhabdomyolysis

rheumatoid arthritis, neurologic complications of

seizure, breakthrough

seizure, children

seizure, classification of

seizure, complications following

seizure, diagnosis of

seizure, differential diagnosis of

seizure, drug-induced

seizure, elderly

seizure, focal

seizure, intractable

seizure, intractable, treatment of

seizure, maternal

seizure, minor motor

seizure, non-treatment of

seizure, paradoxical

seizure, petit mal

seizure, post traumatic

seizure, pregnancy

seizure, prevention of

seizure, prognosis in childhood

seizure, psychomotor-temporal lobe

seizure, psychosocial aspects of

seizure, recurrent

seizure, surgical treatment of

seizure, tonic-clonic

seizure, treatment of

seizure, treatment of, first

seizure, treatment of, monotherapy

seizure, treatment of, polytherapy

seizure, withdrawal

seizure, women

seizure, workup of

selective serotonin reuptake inhibitors

sertraline

serum glutamic oxaloacetic transaminase

serum sickness

sexual dysfunction in neurologic disease

skin, lesions in neurologic disorders

sodium valproate

sodium valproate, intravenous

sodium valproate, toxicity

somnolence

sore throat

spina bifida

splenium of corpus callosum

statin therapy

status epilepticus

steroid

Stevens-Johnson syndrome

stillbirth

subarachnoid hemorrhage

sympathomimetic drugs

systemic lupus erythematosus, drug induced

temporal lobe, status

toxic epidermal necrolysis

toxins, nervous system

trauma

treatment of neurologic disorder

tremor

tremor, cerebellar

tremor, classification

tremor, differential diagnosis of

tremor, intention

tremor, rubral

trigeminal neuralgia

trigeminal neuralgia, treatment of

trimethadione

trimethoprim-sulfamethoxazole

ultrasonography

ultrasonography, head, fetus-neonate

vitamin supplementation

Showing articles 750 to 800 of 5166 << Previous Next >>

Andexanet Alfa for Acute Major Bleeding Associated with Factor Xa Inhibitors
NEJM 375:1131-1141,1185, Connolly, S.J.,et al, 2016

Stroke Outcomes with use of Antithrombotics within 24 hours after Recanalization Treatment
Neurol 87:996-1002, Jeong, H.G.,et al, 2016

Association Between MRI Exposure During Pregnancy and Fetal and Childhood Outcomes
JAMA 316:952-961, Ray, J.G.,et al, 2016

Transient Deficits after Inadvertent Intrathecal Trigger-point Injection with Lidocaine
Neurol 87:848-849, Bereczki, D., et al, 2016

Preventing Shingles and Its Complications in Older Persons
NEJM 375:1079-1080, Neuzil, K.M.,et al, 2016

A 73-year-old Man with Sarcoidosis and Multifocal Ischemic Strokes
Neurol 87:e119-e123, Pichler, M.,et al, 2016

Acquired Hepatocerebral Degeneration
Neurol 87:e144, Bateman, J.R. & Roque, D.A., 2016

Safety and Outcome of Intra-Arterial Treatment for Basilar Artery Occlusion
JAMA Neurol 73:1225-1230, Van Houwelingen, R.C.,et al, 2016

Clinical Relevance of Microbleeds in Acute Stroke Thrombolysis
Neurol 87:1534-1541, Charidimou, A.,et al, 2016

A Benign But Potentially Life-Threatening Headache
Neurol 87:e168-e173, Zhang, D.,et al, 2016

Short Time Interval Between Neurologic Event and Carotid Surgery is Not Associated with an Increased Procedural Risk
Stroke 47:2783-2790, Tsantilas, P.,et al, 2016

Stroke Risk and Mortality in Patients with Ventricular Assist Devices
Stroke 47:2702-2706,2677, Parikh, N.S.,et al, 2016

Early Start of DOAC after Ischemic Stroke
Neurol 87:1856-1862,1652, Seiffge, D.J.,et al, 2016

Facial Grimacing and Sensorineural Hearing Loss in a Woman with Cirrhosis of the Liver
Neurol 87:e239, Sgobbi de Souza, P.V.,et al, 2016

Clinicopathologic Conference, Aqueductal Stenosis with Hydrocephalus
NEJM 375:2583-2593, Case 40-2016, 2016

Neonatal Abstinence Syndrome
NEJM 375:2468-2479, McQueen, K. & Murphy-Oikonen, J., 2016

Use of MRI in the Diagnosis of Fetal Brain Abnormalities in Utero (MERIDIAN): A Multicentre, Prospective Cohort Study
, Griffiths, P.D.,et al, 2016

Clinicopathologic Conference, Oligdendroglioma II/IV with IDH1 R132H mutation and codelation of 1p and 19q
NEJM 375:2381-2389, Case 38-206, 2016

Tongue Fasciculations in Organophosphate Poisoning
NEJM 375:e47, Bande, L.R., 2016

Long-Term Treatment of Epilepsy with Everolimus in Tuberous Sclerosis
Neurol 87:2408-2415, Krueger, D.A.,et al, 2016

Acute Cholecystitis During Treatment with Alemtuzumab in 3 Patients with RRMS
Neurol 87:2380-2381, Pfeuffer, S.,et al, 2016

Acute Hippocampal and Chronic Diffuse White Matter Involvement in Severe Methanol Intoxication
Neurol 87:2382-2383, Takeshige, H.,et al, 2016

Outcomes with Edoxaban Versus Warfarin in Patients with Previous Cerebrovascular Events
Stroke 47:2075-2082, Rost, N.S.,et al, 2016

Repeated Intravenous Thrombolysis for Early Recurrent Stroke
Stroke 47:2133-2135, Kahles, T.,et al, 2016

Diagnostic Yield and Safety of Brain Biopsy for Suspected Primary Central Nervous System Angiitis
Stroke 47:2127-2129, Torres, J.,et al, 2016

Clinicopathologic Conference, Somnolence due to the Cerebral Fat Embolism Syndrome
NEJM 375:370-378, Case 23-2016, 2016

Which Oral Anticoagulation for Atrial Fibrillation?
JAMA 315:2117-2118, The Medical Letter, 2016

Malignancies after Mitoxantrone for Multiple Sclerosis
Neurol 86:2203-2207, Buttmann, M.,et al, 2016

Fulminant Central Nervous System Nocardiosis in a Patient Treated with Alemtuzumab for Relapsing-Remitting Multiple Sclerosis
JAMA Neurol 73:757-759, Penkert, H.,et al, 2016

Myasthenia Gravis Treated with Autologous Hematopoietic Stem Cell Transplantation
JAMA Neurol 73:652-658,624, Bryant, A.,et al, 2016

Risk of Symptomatic Intracerebral Hemorrhage after Intravenous Thrombolysis in Patients with Acute Ischemic Stroke and High Cerebral Microbleed Burden
JAMA Neurol 73:675-683,632, Tsivgoulis, G.,et al, 2016

Hemorrhagic Reversible Cerebral Vasoconstriction Syndrome
Stroke 47:1742-1747, Topcuoglu, M.A.,et al, 2016

Majority of 30-Day Readmissions after Intracerebral Hemorrhage are Related to Infections
Stroke 47:1768-1771, Lord, A.S.,et al, 2016

Orolingual Angioedema During or After Thrombolysis for Cerebral Ischemia
Stroke 47:1825-1830, Myslimi, F.,et al, 2016

Use of Antithrombotic Therapy and Long-Term Clinical Outcome Among Patients Surviving Intracerebral Hemorrhage
Stroke 47:1837-1843, Ottosen, T.P.,et al, 2016

Safety and Diagnostic Value of Brain Biopsy in HIV patients: a Case Series and Meta-Analysis of 1209 Patients
JNNP 87:722-733, Lee, A.M.,et al, 2016

And Why Not Thrombolysis in the Ambulance (At Least for Some)?
Neurol 87:214-219, Rosenberg, G. & Steiner, I., 2016

Rebound Syndrome in Patients with Multiple Sclerosis after Cessation of Fingolimod Treatment
JAMA Neurol 73:790-794, Hatcher, S.E.,et al, 2016

Clinicopathologic Conference, Fulminant Liver Failure Associated with Hepatitis B Virus Infection
NEJM 375:163-171, Case 21-2016, 2016

A 62-Year-Old Woman with Bizarre Behavior and Recurrent Episodes of Behavioral Arrest
Neurol 86:e62-e65, Briglia, H.,et al, 2016

Statin-Associated Autoimmune Myopathy
NEJM 374:664-669, Mammen, A.L., 2016

Pioglitazone after Ischemic Stroke or Transient Ischemic Attack
NEJM 374: DOI:10.1056/NEJMoa1506930, Kernan, W.N.,et al, 2016

Safety of Pregnancy After Cerebral Venous Thrombosis
Stroke 47:713-718, Aguiar de Sousa, D.,et al, 2016

Hydrocephalus in Children
Lancet 387:788-799, Kahle, K.T.,et al, 2016

Infective Endocarditis
Lancet 387:882-893, Cahill, T.J. & Prendergast, B.D., 2016

Community-Acquired Bacterial Meningitis in Adults with Cancer or a History of Cancer
Neurol 86:860-866, Costerus, J.M.,et al, 2016

Antibiotic-Associated Encephalopathy
Neurol 86:963-971, Bhattacharyya, S.,et al, 2016

Myasthenia Gravis Exacerbation after Discontinuing Mycophenolate
Neurol 86:1159-1163, Oskarsson, B.,et al, 2016

Association Between Age and Risk of Stroke or Death from Carotid Endarterectomy and Carotid Stenting: A Meta-Analysis of Pooled Patient Data from Four Randomised Trials
Lancet 387:1305-1311, Howard, G.,et al, 2016

Safety of Endovascular Thrombectomy in Patients Receiving Non-Vitamin K Antagonist Oral Anticoagulants
Stroke 47:1127-1130, Purrucker, J.C.,et al, 2016

Showing articles 750 to 800 of 5166 << Previous Next >>